BETA: Please send your feedback!

Flexion Therapeutics

NAS:FLXN

Biotechnology

$551.95mm
SMALL cap
$14.58 (2.60%)
17.0144%
since start of 2019
  • 3
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 3
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Flexion Therapeutics, Inc. is a pharmaceutical company, which focuses on the development and commercialization of novel, local therapies. The firm specializes in treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.
website

Headquarters

10 Mall Road
Suite 301
Burlington, MA 01803

Executives

Name Title Gender
Kerry A. Wentworth Vice President-Regulatory Affairs & Quality Female
Scott D. Kelley, MD Vice President-Medical Affairs Male
Patrick J. Mahaffy Chairman Male
Michael D. Clayman, MD President, Chief Executive Officer, CFO & Director Male
Neil Bodick, MD, PhD Chief Scientific Officer Male
Yamo Deniz, MD Chief Medical Officer Male
Rose Villandry Vice President-Human Resources Female
Dan Leblanc Senior Vice President-CMC Operations Male
Scott Young Senior Director-Corporate Communications & IR Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 3

Flexion Therapeutics - Competitors and Related Companies

How Flexion Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.

Flexion Therapeutics

NAS:FLXN

Biotechnology

$551.95mm
SMALL cap
$14.58 (2.60%)
17.0144%
since start of 2019
  • 3
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 3
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…